AAAAAA

   
Results: 1-10 |
Results: 10
THE INFLUENCE OF CIMETIDINE ON THE DISPOSITION KINETICS OF THE ANTIDEPRESSANT VENLAFAXINE
Authors: TROY SM RUDOLPH R MAYERSOHN M CHIANG ST
Citation: Sm. Troy et al., THE INFLUENCE OF CIMETIDINE ON THE DISPOSITION KINETICS OF THE ANTIDEPRESSANT VENLAFAXINE, Journal of clinical pharmacology, 38(5), 1998, pp. 467-474
PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE POTENTIAL-DRUG INTERACTION BETWEEN VENLAFAXINE AND ETHANOL
Authors: TROY SM TURNER MB UNRUH M PARKER VD CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE POTENTIAL-DRUG INTERACTION BETWEEN VENLAFAXINE AND ETHANOL, Journal of clinical pharmacology, 37(11), 1997, pp. 1073-1081
PHARMACOKINETICS AND EFFECT OF FOOD ON THE BIOAVAILABILITY OF ORALLY-ADMINISTERED VENLAFAXINE
Authors: TROY SM PARKER VP HICKS DR POLLACK GM CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETICS AND EFFECT OF FOOD ON THE BIOAVAILABILITY OF ORALLY-ADMINISTERED VENLAFAXINE, Journal of clinical pharmacology, 37(10), 1997, pp. 954-961
BIOAVAILABILITY OF ONCE-DAILY VENLAFAXINE EXTENDED-RELEASE COMPARED WITH THE IMMEDIATE-RELEASE FORMULATION IN HEALTHY ADULT VOLUNTEERS
Authors: TROY SM DILEA C MARTIN PT ROSEN AS FRUNCILLO RJ CHIANG ST
Citation: Sm. Troy et al., BIOAVAILABILITY OF ONCE-DAILY VENLAFAXINE EXTENDED-RELEASE COMPARED WITH THE IMMEDIATE-RELEASE FORMULATION IN HEALTHY ADULT VOLUNTEERS, Current therapeutic research, 58(8), 1997, pp. 492-503
PHARMACOKINETICS OF ONCE-DAILY VENLAFAXINE EXTENDED-RELEASE IN HEALTHY-VOLUNTEERS
Authors: TROY SM DILEA C MARTIN PT LEISTER CA FRUNCILLO RJ CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETICS OF ONCE-DAILY VENLAFAXINE EXTENDED-RELEASE IN HEALTHY-VOLUNTEERS, Current therapeutic research, 58(8), 1997, pp. 504-514
PHARMACOKINETIC INTERACTION BETWEEN MULTIPLE-DOSE VENLAFAXINE AND SINGLE-DOSE LITHIUM
Authors: TROY SM PARKER VD HICKS DR BOUDINO D CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETIC INTERACTION BETWEEN MULTIPLE-DOSE VENLAFAXINE AND SINGLE-DOSE LITHIUM, Journal of clinical pharmacology, 36(2), 1996, pp. 175-181
THE PHARMACOKINETICS OF VENLAFAXINE WHEN GIVEN IN A TWICE-DAILY REGIMEN
Authors: TROY SM PARKER VD FRUNCILLO RJ CHIANG ST
Citation: Sm. Troy et al., THE PHARMACOKINETICS OF VENLAFAXINE WHEN GIVEN IN A TWICE-DAILY REGIMEN, Journal of clinical pharmacology, 35(4), 1995, pp. 404-409
PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE POTENTIAL-DRUG INTERACTION BETWEEN VENLAFAXINE AND DIAZEPAM
Authors: TROY SM LUCKI I PEIRGIES AA PARKER VD KLOCKOWSKI PM CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE POTENTIAL-DRUG INTERACTION BETWEEN VENLAFAXINE AND DIAZEPAM, Journal of clinical pharmacology, 35(4), 1995, pp. 410-419
DIFFERENCES IN PHARMACOKINETICS AND COMPARATIVE BIOAVAILABILITY BETWEEN PREMARIN(R) AND ESTRATAB(R) IN HEALTHY POSTMENOPAUSAL WOMEN
Authors: TROY SM HICKS DR PARKER VD JUSKO WJ ROFSKY HE PORTER RJ
Citation: Sm. Troy et al., DIFFERENCES IN PHARMACOKINETICS AND COMPARATIVE BIOAVAILABILITY BETWEEN PREMARIN(R) AND ESTRATAB(R) IN HEALTHY POSTMENOPAUSAL WOMEN, Current therapeutic research, 55(4), 1994, pp. 359-372
THE EFFECT OF RENAL-DISEASE ON THE DISPOSITION OF VENLAFAXINE
Authors: TROY SM SCHULTZ RW PARKER VD CHIANG ST BLUM RA
Citation: Sm. Troy et al., THE EFFECT OF RENAL-DISEASE ON THE DISPOSITION OF VENLAFAXINE, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 14-21
Risultati: 1-10 |